🚀 VC round data is live in beta, check it out!
Naturland Holding Valuation Multiples
Discover revenue and EBITDA valuation multiples for Naturland Holding and similar public comparables like Captor Therapeutics, Genelux, Medivir, Bioceltix and more.
Naturland Holding Overview
About Naturland Holding
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.
Founded
N/A
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$125M
Naturland Holding Financials
Naturland Holding reported last fiscal year revenue of $20M and EBITDA of $6M.
In the same fiscal year, Naturland Holding generated $11M in gross profit, $6M in EBITDA, and $5M in net income.
Naturland Holding P&L
In the most recent fiscal year, Naturland Holding reported revenue of $20M and EBITDA of $6M.
Naturland Holding expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $20M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $11M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 57% | XXX | XXX | XXX |
| EBITDA | — | XXX | $6M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 33% | XXX | XXX | XXX |
| Net Profit | — | XXX | $5M | XXX | XXX | XXX |
| Net Margin | — | XXX | 23% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Naturland Holding Stock Performance
Naturland Holding has current market cap of $125M, and enterprise value of $125M.
Market Cap Evolution
Naturland Holding's stock price is $9.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $125M | $125M | -0.7% | XXX | XXX | XXX | $0.33 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNaturland Holding Valuation Multiples
Naturland Holding trades at 6.3x EV/Revenue multiple, and 22.0x EV/EBITDA.
Naturland Holding Financial Valuation Multiples
As of April 19, 2026, Naturland Holding has market cap of $125M and EV of $125M.
Equity research analysts estimate Naturland Holding's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Naturland Holding has a P/E ratio of 27.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $125M | XXX | $125M | XXX | XXX | XXX |
| EV (current) | $125M | XXX | $125M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 6.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 22.0x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 19.2x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 11.1x | XXX | XXX | XXX |
| P/E | — | XXX | 27.2x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 326.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Naturland Holding Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Naturland Holding Margins & Growth Rates
Naturland Holding's revenue in the last fiscal year grew by 9%.
Naturland Holding Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 29% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 12% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 24% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Naturland Holding Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Naturland Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| Captor Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Genelux | XXX | XXX | XXX | XXX | XXX | XXX |
| Medivir | XXX | XXX | XXX | XXX | XXX | XXX |
| Bioceltix | XXX | XXX | XXX | XXX | XXX | XXX |
| Maat Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Naturland Holding M&A Activity
Naturland Holding acquired XXX companies to date.
Last acquisition by Naturland Holding was on XXXXXXXX, XXXXX. Naturland Holding acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Naturland Holding
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNaturland Holding Investment Activity
Naturland Holding invested in XXX companies to date.
Naturland Holding made its latest investment on XXXXXXXX, XXXXX. Naturland Holding invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Naturland Holding
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Naturland Holding
| Where is Naturland Holding headquartered? | Naturland Holding is headquartered in Hungary. |
| Is Naturland Holding publicly listed? | Yes, Naturland Holding is a public company listed on Budapest Stock Exchange. |
| What is the stock symbol of Naturland Holding? | Naturland Holding trades under NATURLAND ticker. |
| When did Naturland Holding go public? | Naturland Holding went public in 2022. |
| Who are competitors of Naturland Holding? | Naturland Holding main competitors are Captor Therapeutics, Genelux, Medivir, Bioceltix. |
| What is the current market cap of Naturland Holding? | Naturland Holding's current market cap is $125M. |
| What is the current revenue of Naturland Holding? | Naturland Holding's last fiscal year revenue is $20M. |
| What is the current EV/Revenue multiple of Naturland Holding? | Current revenue multiple of Naturland Holding is 6.3x. |
| Is Naturland Holding profitable? | No, Naturland Holding is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.